Strs Ohio Sells 9,963 Shares of Astera Labs, Inc. $ALAB

Strs Ohio cut its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 76.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,012 shares of the company’s stock after selling 9,963 shares during the quarter. Strs Ohio’s holdings in Astera Labs were worth $590,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ALAB. Great Valley Advisor Group Inc. raised its stake in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after buying an additional 90 shares during the last quarter. Straight Path Wealth Management increased its position in shares of Astera Labs by 1.5% during the 2nd quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after purchasing an additional 100 shares during the last quarter. Rye Brook Capital LLC boosted its holdings in shares of Astera Labs by 1.1% in the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after buying an additional 100 shares during the last quarter. First Horizon Advisors Inc. grew its position in Astera Labs by 12.4% during the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after buying an additional 108 shares during the period. Finally, Merit Financial Group LLC increased its holdings in Astera Labs by 3.1% during the third quarter. Merit Financial Group LLC now owns 5,683 shares of the company’s stock valued at $1,113,000 after buying an additional 170 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 6.1%

Shares of ALAB opened at $150.62 on Friday. The business’s 50 day moving average is $163.98 and its 200 day moving average is $171.15. The company has a market capitalization of $25.44 billion, a PE ratio of 135.69, a price-to-earnings-growth ratio of 2.19 and a beta of 1.50. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same period last year, the firm posted $0.23 EPS. The company’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Buying and Selling

In other Astera Labs news, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $1,653,806.70. Following the sale, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. The trade was a 5.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 4,620 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares in the company, valued at $21,275,217.60. This trade represents a 3.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 576,936 shares of company stock worth $87,409,540 in the last 90 days. 12.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ALAB. Raymond James Financial assumed coverage on shares of Astera Labs in a research note on Friday, November 21st. They set a “hold” rating on the stock. Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. TD Cowen restated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $190.63.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.